4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China

4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy

4/1/2025China Accelerates Brain Chip Trials After Initial Success

3/31/2025Roche's Ocrevus Receives Chinese Approval for MS

3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...

3/31/2025BMS's Opdivo and Yervoy Combio Approved in China

3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...

3/28/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...

3/28/2025AstraZeneca Advances AZD0120 CAR-T Trial for Lupus

3/28/2025Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...

3/28/2025GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...

3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...

3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment

3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...

3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...

3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...

3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...

3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...

3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...

3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China

3/21/2025Junshi's Toripalimab Receives 11th Approval in China

3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...

3/21/2025Gilead's Trodelvy Receives Second Approval in China

3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...

3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...

3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS

Page:5/14 Total number of articles:409: [First][<<] [3] [4] [5] [6] [7] [>>] [End]